tm
Seeing Is Believing
tm
Seeing Is Believing
AMAM is currently covered by 6 analysts with an average price target of $34.2. This is a potential upside of $6.2 (22.14%) from yesterday's end of day stock price of $28.
Ambrx Biopharma American Depositary Shares's activity chart (see below) currently has 3 price targets and 23 ratings on display. The stock rating distribution of AMAM is 73.68% BUY and 26.32% HOLD.
Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 101 days.
Highest price target for AMAM is $28, Lowest price target is $6, average price target is $34.2.
Most recent stock forecast was given by JOEL BEATTY from BAIRD on 16-Jan-2024. First documented stock forecast 28-Feb-2022.
Currently out of the existing stock ratings of AMAM, 14 are a BUY (73.68%), 5 are a HOLD (26.32%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$22
$-6 (-21.43%)
$22
1 years 2 days ago
(16-Jan-2024)
5/6 (83.33%)
$-5.68 (-20.52%)
113
Hold
$15
1 years 8 days ago
(10-Jan-2024)
3/3 (100%)
$3.28 (27.99%)
65
Hold
$28
$26
1 years 9 days ago
(09-Jan-2024)
2/2 (100%)
$0.45 (1.63%)
105
Hold
$9
$-19 (-67.86%)
$10
1 years 2 months 3 days ago
(15-Nov-2023)
2/3 (66.67%)
$-0.45 (-4.76%)
181
Buy
$32
$4 (14.29%)
$33
1 years 2 months 4 days ago
(14-Nov-2023)
0/3 (0%)
$22.99 (255.16%)
What is AMAM (Ambrx Biopharma American Depositary Shares) average time for price targets to be met?
Which analyst has the current highest performing score on AMAM (Ambrx Biopharma American Depositary Shares) with a proven track record?
Which analyst has the current lower performing score on AMAM (Ambrx Biopharma American Depositary Shares) with a proven track record?
Which analyst has the most public recommendations on AMAM (Ambrx Biopharma American Depositary Shares)?
Which analyst is the currently most bullish on AMAM (Ambrx Biopharma American Depositary Shares)?
Which analyst is the currently most reserved on AMAM (Ambrx Biopharma American Depositary Shares)?
